Structure Therapeutics Inc. - Depositary Receipt (Common Stock)
US ˙ NasdaqGM ˙ US86366E1064

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Daniel G Welch. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Daniel G Welch har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:RARE / Ultragenyx Pharmaceutical Inc. Director 32.690
US:NUVB / Nuvation Bio Inc. Director 659.947
US:SGEN / Seagen Inc Director 0
US:GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock) Director 123.508
US:ICPT / Intercept Pharmaceuticals Inc Director 2.966
US:AVXS / AveXis, Inc. Director 0
US:HPTX / Hyperion Therapeutics Inc Director 0
US:ITMN / Chairman, CEO and President, Director 0
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Daniel G Welch. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock) – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock). Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock) Insider Trades
Insidersalg GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock) – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock). Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock) Insider Trades
Insiderkøb NUVB.WS / Panacea Acquisition Corp. - Equity Warrant – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock). Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

NUVB.WS / Panacea Acquisition Corp. - Equity Warrant Insider Trades
Insidersalg NUVB.WS / Panacea Acquisition Corp. - Equity Warrant – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock). Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

NUVB.WS / Panacea Acquisition Corp. - Equity Warrant Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Daniel G Welch som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2025-05-19 2025-05-15 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
A - Award 5.740 32.690 21,30
2024-06-20 2024-06-18 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
A - Award 5.345 26.950 24,74
2024-05-29 2024-05-24 4 NUVB Nuvation Bio Inc.
Class A Common Stock
M - Exercise 366.744 659.947 125,08 1,64 601.460 1.082.313
2024-05-29 2024-05-24 4 NUVB Nuvation Bio Inc.
Class A Common Stock
M - Exercise 293.203 293.203 1,74 510.173 510.173
2023-12-15 2023-12-14 4 SGEN Seagen Inc.
Common Stock
D - Sale to Issuer -10.725 0 -100,00 229,00 -2.456.025
2023-12-15 2023-12-14 4 SGEN Seagen Inc.
Common Stock
D - Sale to Issuer -4.750 0 -100,00 229,00 -1.087.750
2023-08-29 2023-08-28 4 SGEN Seagen Inc.
Common Stock
S - Sale X -1.610 10.725 -13,05 209,08 -336.619 2.242.383
2023-08-29 2023-08-28 4 SGEN Seagen Inc.
Common Stock
S - Sale X -1.812 6.794 -21,06 209,01 -378.726 1.420.014
2023-08-29 2023-08-28 4 SGEN Seagen Inc.
Common Stock
S - Sale X -1.503 8.606 -14,87 209,16 -314.367 1.800.031
2023-08-29 2023-08-28 4 SGEN Seagen Inc.
Common Stock
M - Exercise 1.812 10.109 21,84 135,63 245.762 1.371.084
2023-06-09 2023-06-07 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
A - Award 3.860 21.605 21,75
2023-06-02 2023-05-31 4 SGEN Seagen Inc.
Common Stock
A - Award 2.044 8.297 32,69
2023-05-16 2023-05-15 4 SGEN Seagen Inc.
Common Stock
S - Sale X -1.864 6.253 -22,96 200,02 -372.837 1.250.725
2023-05-16 2023-05-15 4 SGEN Seagen Inc.
Common Stock
M - Exercise 1.864 8.117 29,81 135,63 252.814 1.100.909
2023-05-03 2023-05-02 4 SGEN Seagen Inc.
Common Stock
S - Sale X -5.835 12.335 -32,11 200,07 -1.167.408 2.467.863
2023-05-03 2023-05-02 4 SGEN Seagen Inc.
Common Stock
S - Sale X -351 6.253 -5,31 200,07 -70.225 1.251.038
2023-05-03 2023-05-02 4 SGEN Seagen Inc.
Common Stock
S - Sale X -3.462 6.604 -34,39 200,10 -692.746 1.321.460
2023-05-03 2023-05-02 4 SGEN Seagen Inc.
Common Stock
M - Exercise 3.462 10.066 52,42 147,50 510.645 1.484.735
2023-05-03 2023-05-02 4 SGEN Seagen Inc.
Common Stock
S - Sale X -3.171 6.604 -32,44 200,05 -634.359 1.321.130
2023-05-03 2023-05-02 4 SGEN Seagen Inc.
Common Stock
M - Exercise 3.171 9.775 48,02 160,33 508.406 1.567.226
2023-05-03 2023-05-02 4 SGEN Seagen Inc.
Common Stock
S - Sale X -1.888 6.604 -22,23 200,05 -377.694 1.321.130
2023-05-03 2023-05-02 4 SGEN Seagen Inc.
Common Stock
M - Exercise 1.888 8.492 28,59 64,38 121.549 546.715
2023-05-03 2023-05-01 4 SGEN Seagen Inc.
Common Stock
S - Sale X -4.890 18.170 -21,21 200,06 -978.293 3.635.090
2023-05-03 2023-05-01 4 SGEN Seagen Inc.
Common Stock
S - Sale X -295 6.604 -4,28 200,06 -59.018 1.321.196
2023-05-03 2023-05-01 4 SGEN Seagen Inc.
Common Stock
S - Sale X -1.990 6.899 -22,39 200,12 -398.239 1.380.628
2023-05-03 2023-05-01 4 SGEN Seagen Inc.
Common Stock
M - Exercise 1.990 8.889 28,84 56,77 112.972 504.629
2023-05-03 2023-05-01 4 SGEN Seagen Inc.
Common Stock
S - Sale X -5.150 6.899 -42,74 200,04 -1.030.206 1.380.076
2023-05-03 2023-05-01 4 SGEN Seagen Inc.
Common Stock
M - Exercise 5.150 12.049 74,65 64,38 331.557 775.715
2023-04-05 2023-04-03 4 SGEN Seagen Inc.
Common Stock
S - Sale X -4.284 12.335 -25,78 202,54 -867.681 2.498.331
2023-04-05 2023-04-03 4 SGEN Seagen Inc.
Common Stock
S - Sale X -3.317 16.619 -16,64 201,51 -668.409 3.348.895
2023-04-05 2023-04-03 4 SGEN Seagen Inc.
Common Stock
S - Sale X -3.124 19.936 -13,55 200,45 -626.206 3.996.171
2023-04-05 2023-04-03 4 SGEN Seagen Inc.
Common Stock
S - Sale X -1.082 4.149 -20,68 202,54 -219.148 840.338
2023-04-05 2023-04-03 4 SGEN Seagen Inc.
Common Stock
S - Sale X -851 5.231 -13,99 201,51 -171.485 1.054.099
2023-04-05 2023-04-03 4 SGEN Seagen Inc.
Common Stock
S - Sale X -817 6.082 -11,84 200,45 -163.768 1.219.137
2023-04-05 2023-04-03 4 SGEN Seagen Inc.
Common Stock
S - Sale X -112 6.899 -1,60 203,05 -22.742 1.400.842
2023-04-05 2023-04-03 4 SGEN Seagen Inc.
Common Stock
M - Exercise 112 7.011 1,62 56,77 6.358 398.014
2023-04-05 2023-04-03 4 SGEN Seagen Inc.
Common Stock
S - Sale X -7.158 6.899 -50,92 202,51 -1.449.567 1.397.116
2023-04-05 2023-04-03 4 SGEN Seagen Inc.
Common Stock
M - Exercise 7.158 14.057 103,75 56,77 406.360 798.016
2023-04-05 2023-04-03 4 SGEN Seagen Inc.
Common Stock
S - Sale X -5 6.899 -0,07 202,49 -1.012 1.396.979
2023-04-05 2023-04-03 4 SGEN Seagen Inc.
Common Stock
M - Exercise 5 6.904 0,07 66,60 333 459.806
2023-04-05 2023-04-03 4 SGEN Seagen Inc.
Common Stock
S - Sale X -3.575 6.899 -34,13 201,59 -720.684 1.390.769
2023-04-05 2023-04-03 4 SGEN Seagen Inc.
Common Stock
M - Exercise 3.575 10.474 51,82 66,60 238.095 697.568
2023-04-05 2023-04-03 4 SGEN Seagen Inc.
Common Stock
S - Sale X -5.680 6.899 -45,15 200,71 -1.140.033 1.384.698
2023-04-05 2023-04-03 4 SGEN Seagen Inc.
Common Stock
M - Exercise 5.680 12.579 82,33 66,60 378.288 837.761
2023-04-05 2023-04-03 4 SGEN Seagen Inc.
Common Stock
S - Sale X -995 6.899 -12,60 200,11 -199.109 1.380.559
2023-04-05 2023-04-03 4 SGEN Seagen Inc.
Common Stock
M - Exercise 995 7.894 14,42 38,82 38.626 306.445
2023-03-17 2023-03-15 4 SGEN Seagen Inc.
Common Stock
S - Sale X -1.246 23.060 -5,13 200,05 -249.262 4.613.153
2023-03-17 2023-03-15 4 SGEN Seagen Inc.
Common Stock
S - Sale X -320 6.899 -4,43 200,05 -64.016 1.380.145
2023-03-17 2023-03-15 4 SGEN Seagen Inc.
Common Stock
S - Sale X -2.037 7.219 -22,01 200,05 -407.502 1.444.161
2023-03-17 2023-03-15 4 SGEN Seagen Inc.
Common Stock
M - Exercise 2.037 9.256 28,22 38,82 79.076 359.318
2023-03-16 2023-03-14 4 SGEN Seagen Inc.
Common Stock
S - Sale X -288 24.306 -1,17 200,00 -57.600 4.861.200
2023-03-16 2023-03-14 4 SGEN Seagen Inc.
Common Stock
S - Sale X -470 12.977 -3,50 200,00 -94.000 2.595.400
2023-03-16 2023-03-14 4 SGEN Seagen Inc.
Common Stock
M - Exercise 470 13.447 3,62 38,82 18.245 522.013
2023-03-16 2023-03-14 4 SGEN Seagen Inc.
Common Stock
S - Sale X -74 12.977 -0,57 200,00 -14.800 2.595.400
2023-03-16 2023-03-13 4 SGEN Seagen Inc.
Common Stock
S - Sale X -173 24.594 -0,70 202,36 -35.008 4.976.842
2023-03-16 2023-03-13 4 SGEN Seagen Inc.
Common Stock
S - Sale X -808 24.767 -3,16 201,53 -162.836 4.991.294
2023-03-16 2023-03-13 4 SGEN Seagen Inc.
Common Stock
S - Sale X -8.210 25.575 -24,30 200,20 -1.643.642 5.120.115
2023-03-16 2023-03-13 4 SGEN Seagen Inc.
Common Stock
S - Sale X -5.758 7.219 -44,37 200,06 -1.151.945 1.444.233
2023-03-16 2023-03-13 4 SGEN Seagen Inc.
Common Stock
S - Sale X -44 13.051 -0,34 202,35 -8.903 2.640.870
2023-03-16 2023-03-13 4 SGEN Seagen Inc.
Common Stock
S - Sale X -214 13.095 -1,61 201,53 -43.127 2.639.035
2023-03-16 2023-03-13 4 SGEN Seagen Inc.
Common Stock
S - Sale X -2.098 13.309 -13,62 200,20 -420.020 2.664.462
2023-03-16 2023-03-13 4 SGEN Seagen Inc.
Common Stock
S - Sale X -7.629 15.407 -33,12 200,30 -1.528.089 3.086.022
2023-03-16 2023-03-13 4 SGEN Seagen Inc.
Common Stock
M - Exercise 7.629 23.036 49,52 39,94 304.702 920.058
2023-03-16 2023-03-13 4 SGEN Seagen Inc.
Common Stock
S - Sale X -1.348 15.407 -8,05 201,53 -271.662 3.104.973
2023-03-16 2023-03-13 4 SGEN Seagen Inc.
Common Stock
M - Exercise 1.348 16.755 8,75 39,94 53.839 669.195
2023-03-16 2023-03-13 4 SGEN Seagen Inc.
Common Stock
S - Sale X -283 15.407 -1,80 202,36 -57.268 3.117.761
2023-03-16 2023-03-13 4 SGEN Seagen Inc.
Common Stock
M - Exercise 283 15.690 1,84 39,94 11.303 626.659
2023-03-16 2023-03-13 4 SGEN Seagen Inc.
Common Stock
M - Exercise 5.758 15.407 59,67 38,82 223.526 598.100
2023-02-09 2023-02-07 4 GPCR Structure Therapeutics Inc.
Ordinary Shares
C - Conversion 123.508 123.508
2022-06-28 2022-06-24 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
A - Award 3.300 17.745 22,85
2022-05-18 2022-05-16 4 NUVB Nuvation Bio Inc.
Stock Option (Right to Buy)
A - Award 118.784 118.784
2022-05-17 2022-05-13 4 SGEN Seagen Inc.
Non-Qualified Stock Option (right to buy)
A - Award 3.676 3.676
2022-05-17 2022-05-13 4 SGEN Seagen Inc.
Common Stock
A - Award 1.503 9.649 18,45
2022-02-11 2021-06-09 5 SGEN Seagen Inc.
Common Stock
G - Gift 33.785 33.785
2022-02-11 2021-06-09 5 SGEN Seagen Inc.
Common Stock
G - Gift -33.785 8.146 -80,57
2021-11-02 2021-10-29 4 NUVB Nuvation Bio Inc.
Stock Option (Right to Buy)
A - Award 45.229 45.229
2021-06-28 2021-06-24 4 RARE Ultragenyx Pharmaceutical Inc.
Stock Option (Right to Buy)
A - Award 4.125 4.125
2021-06-28 2021-06-24 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
A - Award 2.145 14.445 17,44
2021-05-18 2021-05-14 4 SGEN Seagen Inc.
Non-Qualified Stock Option (right to buy)
A - Award 3.462 3.462
2021-05-18 2021-05-14 4 SGEN Seagen Inc.
Common Stock
A - Award 1.402 41.931 3,46
2021-02-12 3 NUVB Nuvation Bio Inc.
No securities owned.
0
2021-02-12 2021-02-10 4 NUVB Nuvation Bio Inc.
Stock Option (Right to Buy)
A - Award 312.750 312.750
2021-02-12 2021-02-10 4 NUVB Nuvation Bio Inc.
Stock Option (Right to Buy)
A - Award 86.184 86.184
2021-02-05 2020-11-02 5 SGEN Seagen Inc.
Common Stock
G - Gift -6.819 40.529 -14,40
2020-11-04 2020-11-02 4 SGEN Seagen Inc.
Non-Qualified Stock Option (right to buy)
M - Exercise -8.750 0 -100,00
2020-11-04 2020-11-02 4 SGEN Seagen Inc.
Non-Qualified Stock Option (right to buy)
M - Exercise -8.750 0 -100,00
2020-11-04 2020-11-02 4 SGEN Seagen Inc.
Non-Qualified Stock Option (right to buy)
M - Exercise -9.518 0 -100,00
2020-11-04 2020-11-02 4 SGEN Seagen Inc.
Non-Qualified Stock Option (right to buy)
M - Exercise -7.982 9.518 -45,61
2020-11-04 2020-11-02 4 SGEN Seagen Inc.
Non-Qualified Stock Option (right to buy)
M - Exercise -14.500 0 -100,00
2020-11-04 2020-11-02 4 SGEN Seagen Inc.
Common Stock
S - Sale -9.250 47.348 -16,34 164,61 -1.522.642 7.793.954
2020-11-04 2020-11-02 4 SGEN Seagen Inc.
Common Stock
S - Sale -14.500 56.598 -20,39 165,06 -2.393.370 9.342.066
2020-11-04 2020-11-02 4 SGEN Seagen Inc.
Common Stock
M - Exercise 14.500 71.098 25,62 19,02 275.790 1.352.284
2020-11-04 2020-11-02 4 SGEN Seagen Inc.
Common Stock
S - Sale -9.518 56.598 -14,40 165,72 -1.577.323 9.379.421
2020-11-04 2020-11-02 4 SGEN Seagen Inc.
Common Stock
M - Exercise 9.518 66.116 16,82 20,06 190.931 1.326.287
2020-11-04 2020-11-02 4 SGEN Seagen Inc.
Common Stock
S - Sale -7.982 56.598 -12,36 166,70 -1.330.599 9.434.887
2020-11-04 2020-11-02 4 SGEN Seagen Inc.
Common Stock
M - Exercise 7.982 64.580 14,10 20,06 160.119 1.295.475
2020-11-04 2020-11-02 4 SGEN Seagen Inc.
Common Stock
S - Sale -8.750 56.598 -13,39 167,34 -1.464.225 9.471.109
2020-11-04 2020-11-02 4 SGEN Seagen Inc.
Common Stock
M - Exercise 8.750 65.348 15,46 36,70 321.125 2.398.272
2020-11-04 2020-11-02 4 SGEN Seagen Inc.
Common Stock
S - Sale -8.750 56.598 -13,39 168,24 -1.472.100 9.522.048
2020-11-04 2020-11-02 4 SGEN Seagen Inc.
Common Stock
M - Exercise 8.750 65.348 15,46 34,25 299.688 2.238.169
2020-06-30 2020-06-26 4 RARE Ultragenyx Pharmaceutical Inc.
Stock Option (Right to Buy)
A - Award 4.250 4.250
2020-06-30 2020-06-26 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
A - Award 2.550 12.300 26,15
2020-06-01 2020-05-28 4 ICPT INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
A - Award 2.966 2.966
2020-06-01 2020-05-28 4 ICPT INTERCEPT PHARMACEUTICALS, INC.
Common Stock
A - Award 1.595 8.060 24,67
2020-05-19 2020-05-15 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
A - Award 3.171 3.171
2020-05-19 2020-05-15 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
A - Award 1.335 56.598 2,42
2020-05-07 2020-05-06 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -205 55.263 -0,37 166,77 -34.188 9.216.211
2020-05-07 2020-05-06 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -2.435 55.468 -4,21 166,23 -404.770 9.220.446
2020-05-07 2020-05-06 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -4.319 57.903 -6,94 164,98 -712.549 9.552.837
2020-05-07 2020-05-06 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -8.041 62.222 -11,44 164,21 -1.320.413 10.217.475
2020-05-07 2020-05-05 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -284 70.263 -0,40 167,99 -47.709 11.803.481
2020-05-07 2020-05-05 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -11.011 70.547 -13,50 167,26 -1.841.700 11.799.691
2020-05-07 2020-05-05 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -5.400 81.558 -6,21 166,27 -897.858 13.560.649
2020-05-07 2020-05-05 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -3.305 86.958 -3,66 165,62 -547.374 14.401.984
2020-01-09 2020-01-07 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -17.500 0 -100,00
2020-01-09 2020-01-07 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 17.500 90.263 24,05 12,76 223.300 1.151.756
2019-06-21 2019-06-20 4 ICPT INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
A - Award 2.174 2.174
2019-06-21 2019-06-20 4 ICPT INTERCEPT PHARMACEUTICALS, INC.
Common Stock
A - Award 1.570 6.465 32,07
2019-06-13 2019-06-11 4 RARE Ultragenyx Pharmaceutical Inc.
Stock Option (Right to Buy)
A - Award 5.000 5.000
2019-06-13 2019-06-11 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
A - Award 3.000 9.750 44,44
2019-05-22 2019-05-20 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
A - Award 7.038 7.038
2019-05-22 2019-05-20 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
A - Award 2.963 72.763 4,24
2018-06-22 2018-06-20 4 ICPT INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
A - Award 2.748 2.748
2018-06-22 2018-06-20 4 ICPT INTERCEPT PHARMACEUTICALS, INC.
Common Stock
A - Award 1.787 4.895 57,50
2018-06-20 2018-06-19 4 RARE Ultragenyx Pharmaceutical Inc.
Stock Option (Right to Buy)
A - Award 5.000 5.000
2018-06-20 2018-06-19 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
A - Award 3.000 6.750 80,00
2018-05-22 2018-05-18 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
A - Award 9.260 9.260
2018-05-22 2018-05-18 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
A - Award 3.700 69.800 5,60
2018-05-15 2018-05-15 4 AVXS AveXis, Inc.
Stock Option (Right to Buy)
D - Sale to Issuer -2.905 0 -100,00
2018-05-15 2018-05-15 4 AVXS AveXis, Inc.
Stock Option (Right to Buy)
D - Sale to Issuer -2.454 0 -100,00
2018-05-15 2018-05-15 4 AVXS AveXis, Inc.
Stock Option (Right to Buy)
D - Sale to Issuer -35.552 0 -100,00
2018-05-15 2018-05-15 4 AVXS AveXis, Inc.
Common Stock
D - Sale to Issuer 1.106 0 -100,00
2018-03-30 2018-03-13 4 AVXS AveXis, Inc.
Stock Option (Right to Buy)
A - Award 2.905 2.905
2018-03-30 2018-03-13 4 AVXS AveXis, Inc.
Common Stock
A - Award 1.106 1.106
2018-02-15 2018-02-13 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -10.000 0 -100,00
2018-02-15 2018-02-13 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -6.881 0 -100,00
2018-02-15 2018-02-13 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 6.881 66.100 11,62 8,38 57.663 553.918
2018-02-15 2018-02-13 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 10.000 59.219 20,32 10,08 100.800 596.928
2017-08-02 2017-07-31 4 ICPT INTERCEPT PHARMACEUTICALS INC
Common Stock
S - Sale X -602 3.108 -16,23 123,93 -74.604 385.163
2017-07-21 2017-07-20 4 ICPT INTERCEPT PHARMACEUTICALS INC
Common Stock
S - Sale X -217 3.710 -5,53 126,76 -27.507 470.280
2017-06-29 2017-06-27 4 ICPT INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock
A - Award 2.036 2.036
2017-06-29 2017-06-27 4 ICPT INTERCEPT PHARMACEUTICALS INC
Common Stock
A - Award 1.423 3.927 56,83
2017-06-22 2017-06-22 4 RARE Ultragenyx Pharmaceutical Inc.
Employee Stock Option (Right to Buy)
A - Award 3.750 3.750
2017-06-22 2017-06-22 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
A - Award 1.875 3.750 100,00
2017-06-01 2017-05-30 4 AVXS AveXis, Inc.
Stock Option (Right to Buy)
A - Award 2.454 2.454
2017-05-23 2017-05-19 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
A - Award 9.260 9.260
2017-05-23 2017-05-19 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
A - Award 3.700 49.219 8,13
2016-07-21 2016-07-19 4 ICPT INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock
A - Award 1.598 1.598
2016-07-21 2016-07-19 4 ICPT INTERCEPT PHARMACEUTICALS INC
Common Stock
A - Award 1.204 2.504 92,62
2016-06-14 2016-06-09 4 RARE Ultragenyx Pharmaceutical Inc.
Employee Stock Option (Right to Buy)
A - Award 3.750 3.750
2016-06-14 2016-06-09 4 RARE Ultragenyx Pharmaceutical Inc.
Common Stock
A - Award 1.875 1.875
2016-05-24 2016-05-20 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
A - Award 9.260 9.260
2016-05-24 2016-05-20 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
A - Award 3.700 45.519 8,85
2016-03-10 2016-03-08 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -25.000 0 -100,00
2016-03-10 2016-03-08 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 25.000 41.819 148,64 9,82 245.500 410.663
2016-02-12 2016-02-10 4 AVXS AveXis, Inc.
Stock Option (Right to Buy)
A - Award 8.385 8.385
2016-02-12 2016-02-10 4 AVXS AveXis, Inc.
Stock Option (Right to Buy)
A - Award 27.167 27.167
2016-02-10 3 AVXS AveXis, Inc.
Common Stock
0
2015-11-27 2015-11-24 4 ICPT INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock
A - Award 3.500 3.500
2015-11-27 2015-11-24 4 ICPT INTERCEPT PHARMACEUTICALS INC
Common Stock
A - Award 1.300 1.300
2015-06-22 2015-06-18 4 RARE Ultragenyx Pharmaceutical Inc.
Stock Option (Right to Buy)
A - Award 7.500 7.500
2015-05-19 2015-05-15 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
A - Award 9.260 9.260
2015-05-19 2015-05-15 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
A - Award 3.700 16.819 28,20
2015-05-08 2015-05-07 4 HPTX HYPERION THERAPEUTICS INC
Stock Option (Right to Buy)
D - Sale to Issuer -4.869 0 -100,00 46,00 -223.974
2015-05-08 2015-05-07 4 HPTX HYPERION THERAPEUTICS INC
Stock Option (Right to Buy)
D - Sale to Issuer -9.800 0 -100,00 46,00 -450.800
2015-05-08 2015-05-07 4 HPTX HYPERION THERAPEUTICS INC
Stock Option (Right to Buy)
D - Sale to Issuer -20.000 0 -100,00 46,00 -920.000
2015-05-08 2015-05-07 4 HPTX HYPERION THERAPEUTICS INC
Common Stock
D - Sale to Issuer -2.617 0 -100,00 46,00 -120.382
2015-04-10 2015-04-08 4 RARE Ultragenyx Pharmaceutical Inc.
Stock Option (Right to Buy)
A - Award 17.500 17.500
2014-10-01 2014-09-29 4 ITMN INTERMUNE INC
Stock options (right to buy)
D - Sale to Issuer -80.000 0 -100,00
2014-10-01 2014-09-29 4 ITMN INTERMUNE INC
Stock options (right to buy)
D - Sale to Issuer -80.000 0 -100,00
2014-10-01 2014-09-29 4 ITMN INTERMUNE INC
Stock options (right to buy)
D - Sale to Issuer -165.000 0 -100,00
2014-10-01 2014-09-29 4 ITMN INTERMUNE INC
Stock options (right to buy)
D - Sale to Issuer -128.975 0 -100,00
2014-10-01 2014-09-29 4 ITMN INTERMUNE INC
Stock options (right to buy)
D - Sale to Issuer -25.000 0 -100,00
2014-10-01 2014-09-29 4 ITMN INTERMUNE INC
Restricted stock units
D - Sale to Issuer -42.250 0 -100,00
2014-10-01 2014-09-29 4 ITMN INTERMUNE INC
Performance stock units
D - Sale to Issuer -24.000 0 -100,00
2014-10-01 2014-09-29 4 ITMN INTERMUNE INC
Common stock
D - Sale to Issuer -23.000 0 -100,00 74,00 -1.702.000
2014-10-01 2014-09-29 4 ITMN INTERMUNE INC
Common stock
U - Other -71.202 23.000 -75,58 74,00 -5.268.948 1.702.000
2014-08-07 2014-08-07 4 ITMN INTERMUNE INC
Stock options (right to buy)
M - Exercise -24.900 0 -100,00
2014-08-07 2014-08-07 4 ITMN INTERMUNE INC
Common stock
S - Sale X -24.900 94.202 -20,91 45,17 -1.124.813 4.255.406
2014-08-07 2014-08-07 4 ITMN INTERMUNE INC
Common stock
M - Exercise X 24.900 119.102 26,43 8,73 217.377 1.039.760
2014-08-07 2014-08-05 4 ITMN INTERMUNE INC
Stock options (right to buy)
M - Exercise -21.025 128.975 -14,02
2014-08-07 2014-08-05 4 ITMN INTERMUNE INC
Stock options (right to buy)
M - Exercise -125.100 24.900 -83,40
2014-08-07 2014-08-05 4 ITMN INTERMUNE INC
Common stock
S - Sale X -146.125 94.202 -60,80 44,95 -6.568.684 4.234.615
2014-08-07 2014-08-05 4 ITMN INTERMUNE INC
Common stock
M - Exercise X 21.025 240.327 9,59 10,10 212.352 2.427.303
2014-08-07 2014-08-05 4 ITMN INTERMUNE INC
Common stock
M - Exercise X 125.100 219.302 132,80 8,73 1.092.123 1.914.506
2014-06-18 2014-06-16 4 ITMN INTERMUNE INC
Stock options (right to buy)
M - Exercise -15.000 0 -100,00
2014-06-18 2014-06-16 4 ITMN INTERMUNE INC
Common stock
S - Sale X -15.000 94.202 -13,74 45,02 -675.252 4.240.673
2014-06-18 2014-06-16 4 ITMN INTERMUNE INC
Common stock
M - Exercise X 15.000 109.202 15,92 19,01 285.150 2.075.930
2014-06-05 2014-06-04 4 ITMN INTERMUNE INC
Common stock
S - Sale -3.914 94.202 -3,99 39,19 -153.401 3.692.040
2014-06-02 2014-05-30 4 ITMN INTERMUNE INC
Restricted stock units
M - Exercise -8.750 26.250 -25,00
2014-06-02 2014-05-30 4 ITMN INTERMUNE INC
Common stock
S - Sale -4.565 98.116 -4,45 40,06 -182.894 3.930.959
2014-06-02 2014-05-30 4 ITMN INTERMUNE INC
Common stock
M - Exercise 8.750 102.681 9,32
2014-06-02 2014-05-29 4 ITMN INTERMUNE INC
Stock options (right to buy)
A - Award 80.000 80.000
2014-06-02 2014-05-29 4 ITMN INTERMUNE INC
Performance stock units
A - Award 24.000 24.000
2014-06-02 2014-05-29 4 ITMN INTERMUNE INC
Restricted stock units
A - Award 16.000 16.000
2014-05-29 2014-05-27 4 HPTX HYPERION THERAPEUTICS INC
Stock Option (right to buy)
A - Award 4.869 4.869
2014-05-29 2014-05-27 4 HPTX HYPERION THERAPEUTICS INC
Common Stock
A - Award 2.617 2.617
2014-05-28 2014-05-27 4 ITMN INTERMUNE INC
Stock options (right to buy)
M - Exercise -6.493 0 -100,00
2014-05-28 2014-05-27 4 ITMN INTERMUNE INC
Stock options (right to buy)
M - Exercise -456 0 -100,00
2014-05-28 2014-05-27 4 ITMN INTERMUNE INC
Common stock
S - Sale X -6.949 93.931 -6,89 40,15 -278.970 3.770.888
2014-05-28 2014-05-27 4 ITMN INTERMUNE INC
Common stock
M - Exercise X 6.493 100.880 6,88 15,40 99.992 1.553.552
2014-05-28 2014-05-27 4 ITMN INTERMUNE INC
Common stock
M - Exercise X 456 94.387 0,49 15,34 6.995 1.447.897
2014-05-28 2014-05-23 4 ITMN INTERMUNE INC
Stock options (right to buy)
M - Exercise -9.544 456 -95,44
2014-05-28 2014-05-23 4 ITMN INTERMUNE INC
Stock options (right to buy)
M - Exercise -25.000 149.999 -14,29
2014-05-28 2014-05-23 4 ITMN INTERMUNE INC
Common stock
S - Sale X -34.544 93.931 -26,89 40,01 -1.381.974 3.757.822
2014-05-28 2014-05-23 4 ITMN INTERMUNE INC
Common stock
M - Exercise X 9.544 128.475 8,02 15,34 146.405 1.970.806
2014-05-28 2014-05-23 4 ITMN INTERMUNE INC
Common stock
M - Exercise X 25.000 118.931 26,62 8,73 218.250 1.038.268
2014-05-21 2014-05-19 4 ITMN INTERMUNE INC
Common stock
M - Exercise 7.388 170.145 4,54 15,34 113.332 2.610.024
2014-05-21 2014-05-19 4 ITMN INTERMUNE INC
Common stock
M - Exercise 4.219 162.757 2,66 15,34 64.719 2.496.692
2014-05-21 2014-05-19 4 ITMN INTERMUNE INC
Common stock
S - Sale X -11.607 93.931 -11,00 38,00 -441.066 3.569.378
2014-05-21 2014-05-19 4 ITMN INTERMUNE INC
Common stock
M - Exercise X 11.607 105.538 12,36 15,34 178.051 1.618.953
2014-05-20 2014-05-16 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
A - Award 8.750 8.750 34,25 299.688 299.688
2014-05-20 2014-05-16 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
A - Award 3.500 13.119 36,39
2014-05-14 2014-05-12 4 ITMN INTERMUNE INC
Common stock
S - Sale -4.175 93.931 -4,26 36,14 -150.873 3.394.403
2014-05-07 2014-05-06 4 ITMN INTERMUNE INC
Common Stock
M - Exercise 6.518 158.538 4,29 15,34 99.986 2.431.973
2014-05-07 2014-05-06 4 ITMN INTERMUNE INC
Common Stock
M - Exercise 1 152.020 0,00 15,34 15 2.331.987
2014-05-07 2014-05-06 4 ITMN INTERMUNE INC
Common Stock
M - Exercise 25.000 152.019 19,68 8,73 218.250 1.327.126
2014-05-07 2014-05-06 4 ITMN INTERMUNE INC
Common Stock
S - Sale X -31.519 98.106 -24,32 36,01 -1.135.012 3.532.836
2014-05-07 2014-05-06 4 ITMN INTERMUNE INC
Common Stock
M - Exercise X 6.518 129.625 5,29 15,34 99.986 1.988.448
2014-05-07 2014-05-06 4 ITMN INTERMUNE INC
Common Stock
M - Exercise X 1 123.107 0,00 15,34 15 1.888.461
2014-05-07 2014-05-06 4 ITMN INTERMUNE INC
Common Stock
M - Exercise X 25.000 123.106 25,48 8,73 218.250 1.074.715
2014-05-07 2014-05-05 4 ITMN INTERMUNE INC
Common Stock
M - Exercise 3.913 127.019 3,18 25,55 99.977 3.245.335
2014-05-07 2014-05-05 4 ITMN INTERMUNE INC
Common Stock
M - Exercise 25.000 123.106 25,48 8,73 218.250 1.074.715
2014-05-07 2014-05-05 4 ITMN INTERMUNE INC
Common Stock
S - Sale X -28.913 98.106 -22,76 33,39 -965.370 3.275.642
2014-05-07 2014-05-05 4 ITMN INTERMUNE INC
Common Stock
M - Exercise X 3.913 127.019 3,18 25,55 99.977 3.245.335
2014-05-07 2014-05-05 4 ITMN INTERMUNE INC
Common Stock
M - Exercise X 25.000 123.106 25,48 8,73 218.250 1.074.715
2014-04-03 2014-04-01 4 ITMN INTERMUNE INC
Common Stock
S - Sale X -3.673 98.106 -3,61 33,57 -123.287 3.293.006
2014-03-05 2014-03-03 4 ITMN INTERMUNE INC
Common Stock
S - Sale -15.655 121.779 -11,39 31,52 -493.483 3.838.766
2014-02-27 2014-02-25 4 ITMN INTERMUNE INC
Common Stock (Right to Buy)
M - Exercise -41.087 0 -100,00
2014-02-27 2014-02-25 4 ITMN INTERMUNE INC
Common Stock
S - Sale X -41.087 137.434 -23,02 32,63 -1.340.767 4.484.801
2014-02-27 2014-02-25 4 ITMN INTERMUNE INC
Common Stock
M - Exercise X 41.087 178.521 29,90 25,55 1.049.773 4.561.212
2014-02-05 2014-02-03 4 ITMN INTERMUNE INC
Common Stock
S - Sale X -20.000 117.434 -14,55 13,08 -261.600 1.536.037
2014-01-21 2014-01-16 4 ITMN INTERMUNE INC
Common Stock
S - Sale X -50.000 37.434 -57,19 18,02 -901.085 674.624
2014-01-14 2014-01-10 4 ITMN INTERMUNE INC
Common Stock
S - Sale X -50.000 87.434 -36,38 17,00 -850.040 1.486.448
2013-12-04 2013-12-02 4 ITMN INTERMUNE INC
Common Stock
S - Sale X -20.000 137.434 -12,70 13,99 -279.800 1.922.702
2013-10-03 2013-10-01 4 ITMN INTERMUNE INC
Stock Option (Right to Buy)
M - Exercise X -50.000 324.999 -13,33
2013-10-03 2013-10-01 4 ITMN INTERMUNE INC
Common Stock
S - Sale X -70.000 157.434 -30,78 15,43 -1.080.016 2.429.018
2013-10-03 2013-10-01 4 ITMN INTERMUNE INC
Common Stock
M - Exercise X 50.000 227.434 28,18 8,73 436.500 1.985.499
2013-06-05 2013-06-04 4 ITMN INTERMUNE INC
Common Stock
F - Taxes -2.819 177.434 -1,56 9,89 -27.889 1.755.426
2013-06-03 2013-05-30 4 ITMN INTERMUNE INC
Stock Option (Right to Buy)
A - Award 165.000 165.000
2013-06-03 2013-05-30 4 ITMN INTERMUNE INC
Restricted Stock Units
A - Award 35.000 35.000
2013-05-21 2013-05-17 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
A - Award 8.750 8.750 36,70 321.125 321.125
2013-05-21 2013-05-17 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
A - Award 3.500 9.619 57,20
2013-05-13 2012-06-08 4 ITMN INTERMUNE INC
Common Stock
F - Taxes -3.007 180.253 -1,64 9,27 -27.863 1.670.242
2013-05-01 2013-04-15 4 HPTX HYPERION THERAPEUTICS INC
Stock Option (right to buy)
A - Award 9.800 9.800
2012-12-04 2012-12-03 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -3.119 6.881 -31,19
2012-12-04 2012-12-03 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 3.119 6.119 103,97 8,38 26.137 51.277
2012-09-05 2012-09-04 4 HPTX HYPERION THERAPEUTICS INC
Stock Option (right to buy)
A - Award 20.000 20.000
2012-07-31 2012-07-27 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -3.000 14.500 -17,14
2012-07-31 2012-07-27 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 3.000 3.000 19,02 57.060 57.060
2012-06-11 2012-06-08 4 ITMN INTERMUNE INC
Common Stock
F - Taxes -23.341 183.260 -11,30 10,02 -233.877 1.836.265
2012-06-06 2012-06-04 4 ITMN INTERMUNE INC
Stock Option (Right to Buy)
A - Award 150.000 150.000
2012-06-06 2012-06-04 4 ITMN INTERMUNE INC
Common Stock
A - Award 30.000 206.601 16,99 10,10 303.000 2.086.670
2012-06-06 2012-06-04 4 ITMN INTERMUNE INC
Common Stock
A - Award 30.000 206.601 16,99 10,10 303.000 2.086.670
2012-05-22 2012-05-18 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
A - Award 17.500 17.500 20,06 351.050 351.050
2012-05-14 2012-05-14 4 ITMN INTERMUNE INC
Common Stock
F - Taxes -2.064 212.601 -0,96 11,75 -24.248 2.497.637
2012-05-14 2012-05-10 4 ITMN INTERMUNE INC
Common Stock
F - Taxes -2.935 214.665 -1,35 11,54 -33.862 2.476.676
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)